Alzchem Group Ag · XETR:ACT
Alzchem — Q3 2019 Earnings Presentation
23 slides from Alzchem's earnings presentation, Nov 14, 2019
Slide 1: Financial Report AlzChem Group AG
Financial Report AlzChem Group AG Andreas Niedermaier, CEO Dr. Georg Weichselbaumer, CSO November 14th, 2019
Slide 2: Disclaimer
DISCLAIMER Cautionary note regarding forward-looking statements This presentation contains forward-looking statements about the business, financial condition and earnings performance of the AlzChem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 3: Agenda
AGENDA Analyst Presentation Q3/2019 EXECUTIVE SUMMARY BUSINESS AND FINANCIAL DETAILS BACK-UP ALZCHEM GROUP – Q3/2019 FINANCIAL REPORT ANALYST PRESENTATION 3
Slide 4: Highlights
HIGHLIGHTS Summary of business development Q3/2019 Financial Report FACTS & DATA • Successful commissioning of the new Creamino® plant at the Trostberg site • Consistent implementation of the expansion strategy of the food supplements product portfolio. Successful launch of the product Livadur® star
Slide 5: New Creamino plant in operation
NEW CREAMINO® PLANT IN OPERATION Official commissioning on September 12th, 2019 INVESTMENT PROJECT FINISHED EUR ~ 50 Mio. ON TIME AND ON BUDGET CONCRETE 10,000 t In addition to the construction of the Creamino® production plant, the following infrastructure adjustments were AREA necessary: ~ 3,700
Slide 6: Creamino – the source of creatine for animal nutrition
CREAMINO® – the source of creatine for animal nutrition Market and Sales update TRIALS • 25 new trials and studies are running • Additional trials in many countries for new customers announced SALES FORCE ORDER POSITION • Additional order South Africa 60 104 • First trial order Turkey, Caucasus 85 •
Slide 7: The sustainable face of Creamino
The sustainable face of Creamino® AlzChem the inventor, producer, patent holder CAPACITY DOSAGE Creamino® SUFFICIENT FOR 21,000 to 0.6 kg / to ~ 35,000,000 to Creamino® PER KG FEED FEED SAVINGS IN THE VOLUME OF ANIMAL FEED SAVINGS ~ 3% SAVING LAND SAVING CO² - SAVINGS ~ 1,050,000 to ~ 150,000 ha(1)
Slide 8: The dietary supplement with pure creatine – the solution
The dietary supplement with pure creatine – the solution CREATINE HEALTH CLAIM DECLINE IN MUSCLE STRENGTH In 2017 the European Commission has approved an additional health-related Loss of muscle strength with increasing age statement (Health Claim) for creatine: Slow decrease: between the age of 30
Slide 9: Financial Overview Q3/2019
FINANCIAL OVERVIEW Q3/2019 Result within guidance Q3 Q3 2018 2019 AlzChem Group yoy % yoy % 2018 2019 1-9 1-9 SALES (in M€) 92.0 99.4 +8.1% 287.2 287.7 +0.2% EBITDA (in M€) 10.4 13.6 +30.4% 41.4 41.4 +0.1% EBITDA margin (in %) 11.3% 13.6% +2.3 pp 14.4% 14.4% -0.0pp Earnings per Share (in €) 0.43 0.5
Slide 10: Agenda
AGENDA Analyst Presentation Q3/2019 EXECUTIVE SUMMARY BUSINESS AND FINANCIAL DETAILS BACK-UP ALZCHEM GROUP – Q3/2019 FINANCIAL REPORT ANALYST PRESENTATION 10
Slide 11: Basics & Intermediates Segment
BASICS & INTERMEDIATES SEGMENT Our integrated system DESCRIPTION The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products - for example in agriculture, steel production and the automotive sector - and as raw materials
Slide 12: Basics & Intermediates Segment
BASICS & INTERMEDIATES SEGMENT Commissioning NITRALZ® supports Q3 success (M€) SALES 16.2% SALES EBITDA SALES ANALYSIS 41.7 37.9 36.9 35.9 35.5 37.8 34.2 33.0 DELTA DELTA 30.3 Q3 01 - 09 7.5% Volume +10.3% +3.7% Price +4.9% +3.0% 115.0 107.0 Currency +1.0% +0.8% Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2017 2017
Slide 13: Specialty Chemicals Segment
SPECIALTY CHEMICALS Segment Our growth focus DESCRIPTION The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals. SELECTED PRODUCTS ALZCHEM GROUP – Q3/2019 FINANCIAL REPORT ANALYST PRESENTATION 13
Slide 14: Specialty Chemicals Segment
SPECIALTY CHEMICALS SEGMENT Inverse seasonal effects due to Creamino® and Custom Synthesis Products (M€) SALES SALES EBITDA SALES ANALYSIS 2.3% 53.9 56.8 -4.9% 49.8 48.9 50.1 51.7 51.0 DELTA DELTA 45.0 44.1 160.5 Q3 01 - 09 152.7 Volume -2.7% -9.5% Price +3.9% +3.1% Currency +1.1% +1.5% -11.5% Q3 Q4
Slide 15: Other & Holding Segment
OTHER & HOLDING SEGMENT Further activities DESCRIPTION The "Other & Holding" segment comprises all activities that cannot be allocated to the other segments. The segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers. ALZCHEM G
Slide 16: Other & Holding Segment
OTHER & HOLDING SEGMENT Stable service sales on prior year level SALES SALES EBITDA SALES ANALYSIS 8.4% 7.0 6.8 7.0 6.6 6.6 6.8 DELTA DELTA 6.5 6.3 6.1 Q3 01 - 09 Volume +6.8% 0.0% Price +1.6% +1.5% Currency 0.0% 0.0% Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 1.5% 2017 2017 2018 2018 2018 2018 2019 2019 2019 19.7
Slide 17: Balance Sheet
BALANCE SHEET AlzChem Group AG (M€) ASSETS COMMENTS • Seasonal trade receivables increase 31.12.2018 29.3 34.4 78.9 19.5 151.5 313.6 • Higher non-current-assets due to capex projects 30.09.2019 27.8 45.7 73.5 26.7 172.0 345.8 • Right of use assets (leasing) have been recognized for the first time in
Slide 18: Cash Flow
CASH FLOW Expansion CAPEX is the basis for further growth Cashflow from ongoing Cashflow from Cashflow from Net increase / decrease operations (Net cash flow) investing activity financing activity in cash and cash equivalents +25.6 +18.3 -32.2 -24.6 +4.9 -1.4 +3.6 -3.0 1-9 1-9 1-9 1-9 1-9 1-9 1-9 1-
Slide 19: Outlook 2019
OUTLOOK 2019 Underlying assumptions Assumptions • No significant changes in market interest rates • Overall economic growth of 2.2% assumed – no economic turmoil (USA, China) • Stability in product registration and energy legislation • US dollar outlook: 1.12 € / US$ Factors to watch • Continuous cl
Slide 20: Outlook 2019
OUTLOOK 2019 Slightly adjusted sales forecast for fiscal year 2019, EBITDA forecast confirmed (M€) SALES Adj. EBITDA COMMENTS 385.0 • As forecasted in the previous year, the first nine months were characterized by Creamino®’s own distribution activities and the postponed range of custom synthesis pr
Slide 21: Financial Calendar
FINANCIAL CALENDAR Upcoming dates 2019 NOV 14 Quarterly Statement 3rd Quarter 2019 2019 NOV 25 - 27 Deutsches Eigenkapitalforum 2019 DEC 02 Berenberg European Conference, London 2019 DEC 31 End of financial year 2020 MARCH 24 Annual Report 2019 2020 MAY 12 Quarterly Statement 1st Quarter 2020 2020 M
Slide 22: Sales
M€ M€ M€ 1,612 EMPLOYEES ~288 SALES ~41EBITDA ~26 OPERATING CASHFLOW Other and Holding ALZCHEM 6.9% PRODUCTS ARE SOLD WORLDWIDE Basics 40.0% & Intermediates SALES YTD 2019/09 INNOVATION SINCE 53.1% 1908 Specialty Chemicals All financial indicators relating to YTD 2019/09 figures
Slide 23: Thank you for your attention!
CONTACT THANK YOU Investor Relations T +49 8621 86-2888 FOR YOUR ATTENTION! F +49 8621 86-502888 ir@alzchem.com WWW.ALZCHEM.COM